Results 111 to 120 of about 504,752 (301)

Assessment of physician compliance to liver function test monitoring guidance for patients treated with lapatinib [PDF]

, 2013
Sarah Landis, Clara Chen, Julie Byrne, Stephen Jones, Rahul K. Dhanda, Jeanenne J. Nelson   +5 more
openalex   +1 more source

Isoniazid in Children – Any Rationale for Post Isoniazid Liver Function Test?

, 2022
Ahmad Fadzil Bin Abdullah, Nur Shafinaz Rusli   +1 more
openalex   +2 more sources

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Liver function tests at admission as marker of severity and prognosis in COVID-19 patients - A retrospective analysis. [PDF]

J Family Med Prim Care, 2023
Himral P, Bhawani R, Bhardwaj M, Sharma N.   +3 more
europepmc   +1 more source

Developing a Causal Model from Liver Function Test Data

, 2002
Masanori Inada, Takao Terano
openalex   +2 more sources

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Value of liver function test for prediction of asymptomatic common bile duct stones in patients with cholecystolithiasis

, 2016
Xiao-Ping Xu, Jianbo Xu, Junqing Hu
openalex   +1 more source

Altered Liver Function Test in Type 2 Diabetes Mellitus Subjects and its Association with Dyslipidaemia and Fasting Blood Sugar: A Cross-sectional Study

, 2023
S. Ramya, S Sindu Priya, Arun Kannan Selvaraju   +2 more
openalex   +1 more source

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns, Jaclyn S. Long, Sergio Lilla, Kelly Hodge, Marcus J. G. W. Ladds, Colin Nixon, Paula Fernández‐Palanca, Sara Zanivan, Pilar Acedo, Stephen P. Pereira, Kevin M. Ryan   +10 more
wiley   +1 more source

Review of: "Liver Function Test Abnormalities and Associated Factors Among Liver Disease Patients at the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia: Cross Sectional Study" [PDF]

A Banerjee
openalex   +3 more sources